Pinnacle Food Group Limited Announces Entry Into a Non-Binding MOU to Explore Establishing an Open Yeast Platform Hub in Hong Kong

Pinnacle Food Group (Nasdaq: PFAI) said its subsidiary PFHK signed a non-binding MOU on April 20, 2026 to explore creating an Open Yeast Platform hub at the Hong Kong-Shenzhen Innovation and Technology Park.

Rhea-AI Summary

Pinnacle Food Group (Nasdaq: PFAI) said its subsidiary PFHK signed a non-binding MOU on April 20, 2026 to explore creating an Open Yeast Platform hub at the Hong Kong-Shenzhen Innovation and Technology Park. The hub would host an open-source DNA parts collection and a strain bank released under an OpenMTA.

Bioboost will provide consulting and technical integration; final establishment depends on definitive agreements and regulatory reviews.

Argus Apr 20 session

+2.33% close to close Open Argus

Details

News Market Reaction – PFAI

In the Apr 20 session, PFAI gained 2.33%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines a non-binding MOU to explore an Open Yeast Platform hub in Hong Kong, ext...

Analysis

This announcement outlines a non-binding MOU to explore an Open Yeast Platform hub in Hong Kong, extending Pinnacle Food’s synbio and precision fermentation build-out with Bioboost. It fits a pattern of lab, collaboration, and strategy updates centered on bio-engineering capabilities. Key watch points include conversion of this framework into definitive agreements, clarity on the hub’s operational scope, and how open-source tools under the OpenMTA framework support the company’s B2B commercialization strategy for high-value biological products.

Key Figures

MOU announcement year: 2026 Open Yeast Collection launch: 2021 Platform components: 2 parts +1 more

MOU announcement year

2026

Press release dateline year

Open Yeast Collection launch

2021

Year Open Yeast Collection was originally established

Platform components

2 parts

Open Yeast Platform consists of two primary parts

DNA parts library size

hundreds

Current library contains hundreds of DNA assembly parts

Historical Context

5 past events · Latest: Apr 15

5 events

1. Apr 15

   Technical milestone

   24h Move

   +1.0%

   Announced first-generation recombinant yeast strain using methanol-free Pichia platform.

2. Mar 13

   Investor Day strategy

   24h Move

   -3.3%

   Outlined Dual-Engine growth strategy and precision fermentation roadmap at Investor Day.

3. Mar 02

   Investor Day announcement

   24h Move

   +2.2%

   Scheduled virtual Investor Day 2026 and non-deal roadshow for global investors.

4. Jan 28

   Biotech collaboration

   24h Move

   +6.8%

   Subsidiary entered research collaboration with Bioboost on precision fermentation initiatives.

5. Nov 24

   Lab initiative

   24h Move

   +0.0%

   Announced bioengineering lab to expand smart agriculture innovation platform with Bioboost.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

open material transfer agreement, openmta, synthetic biology, precision fermentation

4 terms

open material transfer agreement regulatory

"Both the DNA parts and the strains are released under an Open Material Transfer Agreement"

An open material transfer agreement is a standardized legal contract that lets researchers share biological materials (like cells, DNA, or reagents) with few restrictions, allowing reuse and modification while typically preserving basic attribution and safety rules. For investors, it matters because such agreements speed research collaborations and tool dissemination — like giving scientists shared building blocks — which can accelerate innovation but may limit exclusive control over future commercial rights.

openmta regulatory

"Both the DNA parts and the strains are released under an Open Material Transfer Agreement (OpenMTA) framework."

A Material Transfer Agreement (OpenMTA) is a standardized legal framework that makes it easier for research organizations to share biological materials and related information with fewer restrictions than traditional contracts. For investors, it matters because wider, faster sharing can speed research, reduce duplication of effort, and change how intellectual property and commercialization options are managed—similar to replacing custom, slow paperwork with a simple, shared protocol that accelerates teamwork.

synthetic biology medical

"to support synthetic biology research and biotechnology in yeast."

Synthetic biology is the design and construction of new or modified living systems—like reprogramming cells or microbes—to perform useful tasks such as making materials, medicines, or fuels. For investors it signals a platform technology with potential for high growth and disruption, similar to how software transformed industries: early breakthroughs can create new markets, long-term revenue streams, and also carry technical, regulatory, and ethical risks that affect valuation and timing.

precision fermentation medical

"commercial opportunities in precision fermentation."

Precision fermentation uses edited microbes (like yeast or bacteria) as tiny, programmable factories to produce a single, specific ingredient—such as a protein, enzyme or flavor—rather than making whole foods. Think of it like coding a vending machine to dispense one exact product on demand. For investors, it matters because it can cut production costs, speed up scale-up, reduce reliance on traditional agriculture or chemical synthesis, and create new, high-margin products that can reshape markets and regulatory pathways.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, BC and HONG KONG, April 20, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven company operating at the intersection of smart agriculture and bio-engineering, today announced that its subsidiary, Pinnacle Food AgTech HK Limited (PFHK), has entered into a non-binding memorandum of understanding (MOU) with Open Yeast Collection and Bioboost Synbio Consulting Inc. ("Bioboost"). This MOU establishes a preliminary framework to explore the development of an Open Yeast Platform hub located at the Hong Kong-Shenzhen Innovation and Technology Park, a strategic border-zone development uniquely positioned to leverage the integrated technological and regulatory advantages of both Hong Kong and Mainland China.

The Open Yeast Platform consists of two primary parts. The first is the Open Yeast Collection, an open-source collection of DNA parts for assembling genetic constructs in yeast, originally established by Dr. Scott Pownall in 2021. The current library contains hundreds of valuable DNA assembly parts to support synthetic biology research and biotechnology in yeast. The second part is the Open Yeast Strain Bank, an open-access, growing library of yeast strains made available to researchers worldwide. Both the DNA parts and the strains are released under an Open Material Transfer Agreement (OpenMTA) framework. As part of this collaboration framework, Bioboost, a specialized biotechnology advisory firm, will provide strategic consulting and technical integration expertise to facilitate the platform's regional deployment.

With this platform, PFHK aims to curate, localize, and distribute these synthetic biology tools to the broader yeast research community, promoting scientific advancement and collaboration. The Company believes this initiative may enhance its strategic position within Asia's fast-growing bio-engineering ecosystem. By lowering the barriers to entry for yeast-based research, the Company expects to attract potential synergistic partnerships and accelerate its overarching B2B strategy of commercializing high-value biological products.

The ultimate establishment of the hub and the exact scope of operations remain subject to the execution of definitive agreements among the parties and customary regulatory and operational reviews.

Jiulong You, Chief Executive Officer of Pinnacle Food Group Limited, commented: "Entering into this MOU to explore establishing a hub at the Hong Kong-Shenzhen Innovation and Technology Park aligns perfectly with our 'Dual-Engine' growth strategy. By facilitating open-source collaboration through the OpenMTA framework, we look forward to contributing to the global synthetic biology community and building a robust network of research and industry partners around our operations in Hong Kong. We believe this ecosystem has the potential to serve as a catalyst for future innovations and commercial opportunities in precision fermentation."

About Pinnacle Food Group Limited

Pinnacle Food Group Limited (Nasdaq: PFAI) is a technology-driven company operating at the intersection of smart agriculture and bio-engineering. Driven by a "Dual-Engine" strategy, the Company integrates advanced Farming-as-a-Service (FaaS) solutions with cutting-edge precision fermentation and synthetic biology platforms to build highly efficient and sustainable food systems. For more information, please visit the Company's website at www.pinnaclefoodinc.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. federal securities laws. These statements include, but are not limited to, expectations regarding the potential establishment and operation of the Open Yeast Platform hub, the anticipated benefits to the regional synthetic biology ecosystem and the potential for future partnerships and commercialization. These forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks include, among others, the non-binding nature of the MOU, the possibility that definitive agreements may not be executed on favorable terms or at all, and unexpected regulatory or operational challenges at Hong Kong-Shenzhen Innovation and Technology Park. The Company undertakes no obligation to update any forward-looking statements, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pinnacle-food-group-limited-announces-entry-into-a-non-binding-mou-to-explore-establishing-an-open-yeast-platform-hub-in-hong-kong-302746580.html

SOURCE Pinnacle Food Group Limited

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pinnacle Food Group (PFAI) announce on April 20, 2026 about an Open Yeast hub?

Pinnacle Food Group announced a non-binding MOU to explore an Open Yeast hub in Hong Kong-Shenzhen. According to Pinnacle Food Group, the MOU would pair an open DNA parts collection and strain bank under an OpenMTA to support regional synthetic biology research.

Where would the proposed Open Yeast Platform hub for PFAI be located and why is that site chosen?

The hub would be located at the Hong Kong-Shenzhen Innovation and Technology Park to leverage cross-border advantages. According to Pinnacle Food Group, the site offers integrated technological and regulatory access to both Hong Kong and Mainland China.

What are the main components of the Open Yeast Platform mentioned by PFAI?

The platform comprises an Open Yeast Collection of DNA parts and an Open Yeast Strain Bank released under OpenMTA. According to Pinnacle Food Group, the collection contains hundreds of DNA assembly parts supporting yeast synthetic biology research.

What role will Bioboost play in the PFAI Open Yeast hub initiative?

Bioboost will provide strategic consulting and technical integration expertise to support regional deployment. According to Pinnacle Food Group, Bioboost is a biotechnology advisory firm assisting platform integration and operational planning.

Is the Open Yeast hub agreement binding and what are the next steps for PFAI?

No, the agreement is a non-binding MOU; definitive agreements are required to proceed. According to Pinnacle Food Group, final establishment depends on execution of definitive contracts and customary regulatory and operational reviews.